CN110755586A - A topical Chinese medicinal composition - Google Patents

A topical Chinese medicinal composition Download PDF

Info

Publication number
CN110755586A
CN110755586A CN201911091896.8A CN201911091896A CN110755586A CN 110755586 A CN110755586 A CN 110755586A CN 201911091896 A CN201911091896 A CN 201911091896A CN 110755586 A CN110755586 A CN 110755586A
Authority
CN
China
Prior art keywords
parts
traditional chinese
chinese medicine
medicine composition
ginger
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201911091896.8A
Other languages
Chinese (zh)
Inventor
李本强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201911091896.8A priority Critical patent/CN110755586A/en
Publication of CN110755586A publication Critical patent/CN110755586A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/754—Evodia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/285—Aucklandia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • A61K36/835—Aquilaria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to an externally applied traditional Chinese medicine composition. The traditional Chinese medicine composition for external application comprises the following components in parts by weight: 8-12 parts of fructus evodiae; 4-8 parts of flos caryophyllata; 4-8 parts of cassia bark core; 0.3-0.7 parts of musk; 8-12 parts of sandalwood; 8-12 parts of costustoot; 8-12 parts of raw monkshood; 8-12 parts of agilawood; 10-14 parts of radix angelicae; 13-17 parts of bighead atractylodes rhizome; 4-8 parts of borneol; 8-12 parts of dried ginger; 4-8 parts of ginger. The preparation method comprises mixing the raw materials, grinding into powder, adding clear water, mixing, and making into paste according to medical advice. The externally applied traditional Chinese medicine composition has the treatment effects of warming spleen and stomach for dispelling cold, clearing and activating the channels and collaterals, activating meridians and relieving pain and dissipating stagnation.

Description

A topical Chinese medicinal composition
Technical Field
The invention relates to the field of traditional Chinese medicines, in particular to an externally applied traditional Chinese medicine composition.
Background
Blood stasis is a pathological product formed in the course of disease and also a pathogenic factor of some diseases. The formation reasons of the external injury include qi deficiency, qi stagnation, blood cold and blood heat which can cause unsmooth blood circulation to form blood stasis and swelling, and various traumas damage skin and internal organs to cause blood stasis in vivo due to the accumulation of blood from menstruation. In the literature of traditional Chinese medicine, stagnant blood is also called as "lochiorrhea", "cup blood", "blood storage", "septicemia" or "dirty blood". Although the existing traditional Chinese medicine formula has the effects of relaxing tendons and activating collaterals, and promoting blood circulation and removing blood stasis, the effect is not obvious, and the treatment time is long.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides an externally applied traditional Chinese medicine composition, which solves the technical problems and provides an externally applied traditional Chinese medicine composition for warming middle-jiao to dispel cold, clearing and activating the channels and collaterals, activating meridians to relieve pain and dissipating stagnation.
In order to achieve the purpose, the invention provides the following technical scheme:
a traditional Chinese medicine composition for external application comprises the following components in parts by weight: 8-12 parts of fructus evodiae; 4-8 parts of flos caryophyllata; 4-8 parts of cassia bark core; 0.3-0.7 parts of musk; 8-12 parts of sandalwood; 8-12 parts of costustoot; 8-12 parts of raw monkshood; 8-12 parts of agilawood; 10-14 parts of radix angelicae; 13-17 parts of bighead atractylodes rhizome; 4-8 parts of borneol; 8-12 parts of dried ginger; 4-8 parts of ginger.
A traditional Chinese medicine composition for external application comprises the following components in parts by weight: 10 parts of fructus evodiae; 6 parts of flos caryophyllata; 6 parts of cassia bark core; 0.5 part of musk; 10 parts of sandalwood; 10 parts of costustoot; 10 parts of unprocessed monkshood; 10 parts of agilawood; 12 parts of radix angelicae; 15 parts of bighead atractylodes rhizome; 6 parts of borneol; 10 parts of dried ginger; 6 parts of ginger.
A traditional Chinese medicine composition for external application comprises the following components in parts by weight: 8 parts of fructus evodiae; 4 parts of flos caryophyllata; 4 parts of cassia bark core; 0.3 part of musk; 8 parts of sandalwood; 8 parts of costustoot; 8 parts of unprocessed monkshood; 8 parts of agilawood; 11 parts of radix angelicae; 14 parts of bighead atractylodes rhizome; 5 parts of borneol; 12 parts of dried ginger; 7 parts of ginger.
A topical Chinese medicinal composition is prepared by mixing fructus evodiae, flos Caryophylli, cortex Cinnamomi, Moschus, lignum Santali albi, radix aucklandiae, radix Aconiti lateralis Preparata, lignum Aquilariae Resinatum, radix Angelicae Dahuricae, Atractylodis rhizoma, Borneolum Syntheticum, Zingiberis rhizoma and rhizoma Zingiberis recens, grinding into powder of 90-100 meshes, adding clear water, and mixing to obtain paste.
The invention has the beneficial effects that: the externally applied traditional Chinese medicine composition has the treatment effects of warming spleen and stomach for dispelling cold, clearing and activating the channels and collaterals, activating meridians and relieving pain and dissipating stagnation.
For a better understanding of the features and technical content of the present invention, refer to the following detailed description of the invention.
Detailed Description
To further illustrate the technical means adopted by the present invention and the effects thereof, the following detailed description is given with reference to the preferred embodiments of the present invention.
A traditional Chinese medicine composition for external application comprises the following components in parts by weight: 8-12 parts of fructus evodiae; 4-8 parts of flos caryophyllata; 4-8 parts of cassia bark core; 0.3-0.7 parts of musk; 8-12 parts of sandalwood; 8-12 parts of costustoot; 8-12 parts of raw monkshood; 8-12 parts of agilawood; 10-14 parts of radix angelicae; 13-17 parts of bighead atractylodes rhizome; 4-8 parts of borneol; 8-12 parts of dried ginger; 4-8 parts of ginger.
Example 1:
a traditional Chinese medicine composition for external application comprises the following components in parts by weight: 10 parts of fructus evodiae; 6 parts of flos caryophyllata; 6 parts of cassia bark core; 0.5 part of musk; 10 parts of sandalwood; 10 parts of costustoot; 10 parts of unprocessed monkshood; 10 parts of agilawood; 12 parts of radix angelicae; 15 parts of bighead atractylodes rhizome; 6 parts of borneol; 10 parts of dried ginger; 6 parts of ginger.
Example 2:
a traditional Chinese medicine composition for external application comprises the following components in parts by weight: 8 parts of fructus evodiae; 4 parts of flos caryophyllata; 4 parts of cassia bark core; 0.3 part of musk; 8 parts of sandalwood; 8 parts of costustoot; 8 parts of unprocessed monkshood; 8 parts of agilawood; 11 parts of radix angelicae; 14 parts of bighead atractylodes rhizome; 5 parts of borneol; 12 parts of dried ginger; 7 parts of ginger.
The preparation method comprises the following steps:
a topical Chinese medicinal composition is prepared by mixing fructus evodiae, flos Caryophylli, cortex Cinnamomi, Moschus, lignum Santali albi, radix aucklandiae, radix Aconiti lateralis Preparata, lignum Aquilariae Resinatum, radix Angelicae Dahuricae, Atractylodis rhizoma, Borneolum Syntheticum, Zingiberis rhizoma and rhizoma Zingiberis recens, grinding into powder of 90-100 meshes, adding clear water, and mixing to obtain paste.
Clinical data:
case selection: the participants are patients with blood stasis and swelling, 30 patients with blood stasis and swelling in the period from 3 months to 4 months in the period from 2018 are selected, and 30 patients form a treatment group: 15 men and 15 women, the age is 10-17 years, and the average age is 13.4 +/-3.7 years.
Diagnostic criteria:
according to the standard, whether the blood stasis and swelling disappear or not.
Exclusion criteria:
blood stasis and swelling caused by other diseases.
The treatment method comprises the following steps:
treatment groups: the medicine is used 1 time a day, 1 tablet at a time, and is continuously applied for 15 days.
Criteria for efficacy assessment
And (3) curing: the stagnant blood and swelling disappeared in 18 cases.
The effect is shown: blood stasis and swelling disappeared basically, 5 cases.
Improvement: there were traces of blood stasis and swelling in 5 cases.
And (4) invalidation: symptoms were not significantly improved, 2 cases.
As a result:
the total effective rate is 93.33%.
Patient cases:
the Chinese medicinal composition takes effect after 2 days and cures after 10 days due to injury of sports, blood stasis and swelling of legs of a woman aged 16 years, early middle aged and senior.
In 17 years old and young, the Chinese medicinal composition takes effect 1 day later and cures 7 days later due to injury caused by sports, blood stasis and swelling of legs.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.

Claims (4)

1. A traditional Chinese medicine composition for external application is characterized by comprising the following components in parts by weight: 8-12 parts of fructus evodiae; 4-8 parts of flos caryophyllata; 4-8 parts of cassia bark core; 0.3-0.7 parts of musk; 8-12 parts of sandalwood; 8-12 parts of costustoot; 8-12 parts of raw monkshood; 8-12 parts of agilawood; 10-14 parts of radix angelicae; 13-17 parts of bighead atractylodes rhizome; 4-8 parts of borneol; 8-12 parts of dried ginger; 4-8 parts of ginger.
2. The traditional Chinese medicine composition for external application according to claim 1, which comprises the following components in parts by weight: 10 parts of fructus evodiae; 6 parts of flos caryophyllata; 6 parts of cassia bark core; 0.5 part of musk; 10 parts of sandalwood; 10 parts of costustoot; 10 parts of unprocessed monkshood; 10 parts of agilawood; 12 parts of radix angelicae; 15 parts of bighead atractylodes rhizome; 6 parts of borneol; 10 parts of dried ginger; 6 parts of ginger.
3. The traditional Chinese medicine composition for external application according to claim 1, which comprises the following components in parts by weight: 8 parts of fructus evodiae; 4 parts of flos caryophyllata; 4 parts of cassia bark core; 0.3 part of musk; 8 parts of sandalwood; 8 parts of costustoot; 8 parts of unprocessed monkshood; 8 parts of agilawood; 11 parts of radix angelicae; 14 parts of bighead atractylodes rhizome; 5 parts of borneol; 12 parts of dried ginger; 7 parts of ginger.
4. The externally applied traditional Chinese medicine composition for external application according to claim 1, which is prepared by mixing fructus evodiae, flos caryophylli, cortex cinnamomi, musk, sandalwood, radix aucklandiae, radix aconiti lateralis preparata, agilawood, radix angelicae, rhizoma atractylodis macrocephalae, borneol, rhizoma zingiberis and rhizoma zingiberis, grinding into powder of 90-100 meshes, adding clear water, mixing and making into paste.
CN201911091896.8A 2019-11-08 2019-11-08 A topical Chinese medicinal composition Withdrawn CN110755586A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911091896.8A CN110755586A (en) 2019-11-08 2019-11-08 A topical Chinese medicinal composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911091896.8A CN110755586A (en) 2019-11-08 2019-11-08 A topical Chinese medicinal composition

Publications (1)

Publication Number Publication Date
CN110755586A true CN110755586A (en) 2020-02-07

Family

ID=69337137

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911091896.8A Withdrawn CN110755586A (en) 2019-11-08 2019-11-08 A topical Chinese medicinal composition

Country Status (1)

Country Link
CN (1) CN110755586A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101721480A (en) * 2009-12-29 2010-06-09 乌力吉 Traditional Chinese medicine composition for treating diseases of bone, joint and skin and preparation method thereof
CN102755614A (en) * 2012-07-24 2012-10-31 成都中医药大学 Multi-effect acupuncture point application ointment and preparation method
CN105688174A (en) * 2016-03-30 2016-06-22 陈廷明 Traditional Chinese medicine composition for alleviating pain and method for preparing plaster
CN106344855A (en) * 2016-08-29 2017-01-25 张东旭 Medium for external use of moxibustiontherapy through traditional Chinese medicine and preparing method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101721480A (en) * 2009-12-29 2010-06-09 乌力吉 Traditional Chinese medicine composition for treating diseases of bone, joint and skin and preparation method thereof
CN102755614A (en) * 2012-07-24 2012-10-31 成都中医药大学 Multi-effect acupuncture point application ointment and preparation method
CN105688174A (en) * 2016-03-30 2016-06-22 陈廷明 Traditional Chinese medicine composition for alleviating pain and method for preparing plaster
CN106344855A (en) * 2016-08-29 2017-01-25 张东旭 Medium for external use of moxibustiontherapy through traditional Chinese medicine and preparing method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
汤文学: "温胃饮的临床运用", 《江苏中医》 *

Similar Documents

Publication Publication Date Title
CN110585413A (en) Chinese medicinal plaster for treating infantile common cold, cough, abdominal pain and diarrhea, and its preparation method
CN101797335B (en) Chinese medicinal composition for treating functional uterine bleeding
CN101507789B (en) Xiao Bi Tang decoction capable of treating psoriasis and preparation method thereof
CN104524247B (en) One treats migrainous medical composition and its use
CN103330835A (en) Traditional Chinese medicine composition for treating climacteric syndromes
CN101332290A (en) Traditional Chinese medicine composite for treating chronic bronchitis
CN110755586A (en) A topical Chinese medicinal composition
CN100374147C (en) Traditional Chinese medicine preparation for treating mammary gland hyperplasia
CN107823622A (en) A kind of pharmaceutical composition for treating cold urticaria and its production and use
CN108619427B (en) Pain-relieving and acid-reducing herb tea for preventing and treating gouty arthritis
CN106822300B (en) Traditional Chinese medicine preparation for removing acne and beautifying face
CN102319317A (en) Traditional Chinese medicine composition for treating menstrual disorder and preparation method thereof
CN111358902A (en) Traditional Chinese medicine ointment formula applied to fatty liver and processing method thereof
CN104474405A (en) Traditional Chinese medicine composition for treating chloasma
CN103432333B (en) Composition consisting of effective traditional Chinese medicine parts and used for treating hypothyroidism
CN105456974A (en) Traditional Chinese medicine composition for treating congealing cold blood stasis adenomyosis
CN103893480A (en) Traditional Chinese medicine preparation for treating kidney deficiency and blood stasis type oviduct obstructive infertility
CN103239655B (en) Macule-transforming decoction for treating psoriasis
CN103550723B (en) Traditional Chinese medicine preparation for treating Raynaud disease
CN102258589B (en) Deer blood medicinal wine for treating rheumatoid arthritis
CN101607007B (en) Traditional Chinese medicine preparation for treating cerebral circulation insufficiency
Wilson et al. Integrative approach to migraine using traditional European, Indian and Chinese medicine: a case report
CN101912543A (en) Chinese medicinal herb for curing sinusitis
CN106177730A (en) A kind of washing liquid of relieving itching and removing dandruff and preparation method thereof
CN104998346A (en) Belt for treating dysmenorrhea and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20200207